News|Articles|January 14, 2025

MHE January 2025
Volume 35
Issue 1

Out-of-Pocket Limits Increase Utilization | Predictions for 2025

Jerilyn Arneson, Pharm. D, co-founder and officer of the National Association of Medication Access & Patient Advocacy, gives her 2025 prediction.

The lower out-of-pocket maximum in Medicare Part D plans might encourage some patients to use more healthcare services, including prescription drugs, that they previously couldn’t afford and, thus, never had filled. This increased utilization could lead to more people hitting the $2,000 limit and increasing the demand for foundation assistance.

Articles in this issue

almost 2 years ago

Article

Many Believe RFK Jr.’s Views on Vaccination Are Dangerous and Other Findings | MHE State of the Industry Survey Results, Part 1

almost 2 years ago

Article

Lab Power | Predictions for 2025

almost 2 years ago

Article

Here we are Now, Enable us | Predictions for 2025

almost 2 years ago

Article

Advancing Care Coordination, Equity and AI Integration | Predictions for 2025

almost 2 years ago

Article

GLP-1s in a More Mode: More Indications, More Access | Predictions for 2025

almost 2 years ago

Article

Telehealth, the Fully Hybridized Version | Prediction for 2025

almost 2 years ago

Article

Cybersecurity on Health Plan Radar | Predictions for 2025

almost 2 years ago

Article

Simulacra of Data as an Answer | Predictions for 2025

almost 2 years ago

Article

AI Soups up Payer Operations | Predictions for 2025

almost 2 years ago

Article

Digital Lifeline | Predictions for 2025

Get the latest industry news, event updates and more from Managed Healthcare Executive.

Related to this article

November 7th, 2026

8 takeaways from the MHE and Drug Topics post-midterms webinar

Expect Democrats to flex their oversight powers even if President Donald Trump’s veto power blocks their efforts to reverse Medicaid cuts or restore enhanced ACA subsidies. The administration’s most-favored-nation policies and HHS Secretary Kennedy will probably be in the hot seat.

November 6th, 2026

Medicare changes are here to stay. 3 ways health plans can support members through them

Health plans should be using data, digital tools and human support to identify potential disruptions early, and whether a member is changing plans or managing a new health condition, the experience should feel guided rather than overwhelming.

November 6th, 2026

Cigna’s third-quarter earnings show a drop in income from its pharmacy benefit business

Pretax adjusted income from operations from Express Scripts, Cigna's pharmacy benefit manager, fell by 21.5% compared with the third quarter of 2025, while income from operations of its specialty drug business jumped by 15%.

November 6th, 2026

'Bad data in, means bad data out'—pharmacists on the limits of AI in managed care

Annesha White, Pharm.D., M.S., Ph.D., and Fredrick Manasseh, Pharm.D., MBA, BCGP, explain where AI helps managed care pharmacy, where bias creeps in and what skills pharmacists need to oversee it.

November 6th, 2026

FDA approves Weltruza, first once-monthly subcutaneous olanzapine injection for schizophrenia

Teva’s Weltruza delivers olanzapine monthly under the skin, with no loading doses, oral supplementation or post-injection monitoring required.

November 6th, 2026

Christopher Stanley, M.D., MBA, on culture change and implementing value-based care

Value-based care has scored some cost-saving successes, says Christopher Stanley, M.D., MBA, president of Henry Ford Health's Populance. Health systems that build their own value-based care strategy, rather than adopting particular models one by one, will be in the best position to succeed, he says.

November 6th, 2026

On Populance's pivot to internal customers, some early wins and the current state of value-based care | A conversation with Christopher Stanley, M.D.. MBA

The second half of our conversation with Christopher Stanley, M.D., MBA, the president of Henry Ford Health's Populance and the newest member of the Managed Healthcare Executive editorial advisory board.

November 6th, 2026

On becoming a pediatrician, lessons learned in the Army and the Sutter way of doing thing | A conversation with Christopher Stanley, M.D., MBA

The first part of our conversation with Christopher Stanley, M.D., MBA, the president of Henry Ford Health's Populance and the newest member of the Managed Healthcare Executive editorial advisory board.

Trending on Managed Healthcare Executive

WHO adds two Bundibugyo vaccines to Ebola trial in the DRC

On Medicaid cuts, the Medicare Advantage market, commercial insurance and the future of U.S. health insurance: A conversation with Geisinger's Jeremy Gaskill

8 takeaways from the MHE and Drug Topics post-midterms webinar

Cigna’s third-quarter earnings show a drop in income from its pharmacy benefit business

On the advantages of health system-owned health plan, what Medicaid cuts might mean and the future of U.S. health insurance: A conversation with Geisinger's Jeremy Gaskill